Cara Care builds a mobile-first digital therapeutics platform targeting IBS and GERD, with a tech stack centered on React Native and TypeScript across iOS and Android. The company is modernizing its platform while expanding product scope—a signal they're moving beyond single-condition apps toward a broader digestive health ecosystem. Hiring is concentrated in engineering and product roles, with activity accelerating, indicating active development velocity on the core platform.
Cara Care develops a mobile application that combines behavioral, nutritional, and microbial data to guide patients through digestive health management. The platform focuses on conditions including IBS and GERD, positioning itself as a digital therapeutic rather than a traditional health app. Based in Berlin and founded in 2016, the company operates as a small, privately held organization with current projects spanning app feature development, nutritional content creation, and internal people process automation. Their tech foundation is built on React Native for cross-platform mobile delivery, with native Swift and Kotlin layers for platform-specific functionality.
React Native and TypeScript for cross-platform mobile, with Swift for iOS and Kotlin for Android. Testing uses Jest, React Native Testing Library, and Detox. CI/CD runs through GitHub Actions and Bitrise, with monitoring via Sentry.
Berlin, Germany. The company was founded in 2016 and currently employs 11–50 people, with all active hiring concentrated in Germany.
Mobile app development for IBS and GERD management, nutritional therapeutic product features, and patient-centered content. Active projects also include people analytics and employer branding initiatives.
Other companies in the same industry, closest in size